Healthcare · Pharmaceuticals & Biotechnology
No company profile on record yet.
| Fiscal year | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Total income (before exceptional items) | 266† | 845† | — | 953† | 214† |
| Net profit | 63 | 19 | 32 | 50 | 78† |
₹ Crore. † Summed from the four quarterly filings of that fiscal year.
Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.
| Name | Designation | Term end |
|---|---|---|
| Arjun Shanker Bhartia | Executive Director | June 30, 2026 |
| Priyavrat Bhartia | Executive Director | June 30, 2026 |
| Arun Seth | Independent Director | June 30, 2026 |
| Harsh Mahajan | Independent Director | June 30, 2026 |
| Shirish Gundopant Belapure | Independent Director | June 30, 2026 |
| Shivpriya Nanda | Independent Director | June 30, 2026 |
| Sushil Kumar Roongta | Independent Director | June 30, 2026 |
| Vivek Mehra | Independent Director | June 30, 2026 |
| Hari Shanker Bhartia | Non-Executive Director | June 30, 2026 |
| Shyam Sunder Bhartia | Non-Executive Director | June 30, 2026 |
Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.
